BRPI1014720A2 - uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide - Google Patents

uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide

Info

Publication number
BRPI1014720A2
BRPI1014720A2 BRPI1014720A BRPI1014720A BRPI1014720A2 BR PI1014720 A2 BRPI1014720 A2 BR PI1014720A2 BR PI1014720 A BRPI1014720 A BR PI1014720A BR PI1014720 A BRPI1014720 A BR PI1014720A BR PI1014720 A2 BRPI1014720 A2 BR PI1014720A2
Authority
BR
Brazil
Prior art keywords
phenyl
treatment
rheumatoid pain
dimethylaminopropane compounds
dimethylaminopropane
Prior art date
Application number
BRPI1014720A
Other languages
English (en)
Inventor
Klaus Schiene
Ulrich Jahnel
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41050250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1014720(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of BRPI1014720A2 publication Critical patent/BRPI1014720A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1014720A 2009-04-30 2010-04-26 uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide BRPI1014720A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09005980 2009-04-30
PCT/EP2010/002606 WO2010124856A1 (en) 2009-04-30 2010-04-26 Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain

Publications (1)

Publication Number Publication Date
BRPI1014720A2 true BRPI1014720A2 (pt) 2016-04-12

Family

ID=41050250

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014720A BRPI1014720A2 (pt) 2009-04-30 2010-04-26 uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide

Country Status (24)

Country Link
US (4) US20100280128A1 (pt)
EP (2) EP3069717A1 (pt)
JP (1) JP5993303B2 (pt)
KR (4) KR20210027513A (pt)
CN (2) CN102438607A (pt)
AU (1) AU2010243907C1 (pt)
BR (1) BRPI1014720A2 (pt)
CA (1) CA2757757C (pt)
CY (1) CY1118822T1 (pt)
DK (1) DK2424514T3 (pt)
ES (1) ES2625949T3 (pt)
HR (1) HRP20170551T1 (pt)
HU (1) HUE032695T2 (pt)
IL (1) IL215695A (pt)
LT (1) LT2424514T (pt)
MX (1) MX2011011442A (pt)
MY (1) MY174008A (pt)
PH (1) PH12017500270A1 (pt)
PL (1) PL2424514T3 (pt)
PT (1) PT2424514T (pt)
SG (2) SG10201401455WA (pt)
SI (1) SI2424514T1 (pt)
WO (1) WO2010124856A1 (pt)
ZA (1) ZA201107708B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2694049T (lt) 2011-04-05 2018-12-27 GrĆ¼nenthal GmbH Tapentadolis, skirtas skausmo perėjimo į lėtinį prevencijai
PL3272343T3 (pl) 2011-04-29 2020-07-27 Grünenthal GmbH Tapentadol w prewencji i leczeniu depresji i lęku
CA2890270A1 (en) * 2012-11-01 2014-05-08 Torrent Pharmaceuticals Ltd Pharmaceutical composition of tapentadol for parenteral administration
CN108227067B (zh) * 2017-11-13 2021-02-02 南京矽力微电子技术有限公司 一种光学结构以及具有该光学结构的电子设备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
WO2004009062A2 (en) * 2002-07-19 2004-01-29 Khalid Iqbal NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau
EP1562567B1 (de) * 2002-11-22 2017-06-14 Grünenthal GmbH Kombination ausgewählter analgetika mit cox ii-inhibitoren
WO2008134071A1 (en) * 2007-04-26 2008-11-06 Theraquest Biosciences, Inc. Multimodal abuse resistant extended release formulations
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
BRPI0819451A2 (pt) * 2007-11-23 2017-10-03 Protect Pharmaceutical Corp Composição farmacêutica, método para tratar dor, kit farmacêutico, e, uso de uma composição
PL2352494T3 (pl) * 2008-10-30 2020-03-31 Grünenthal GmbH Nowe i silne postaci dawkowania tapentadolu

Also Published As

Publication number Publication date
MX2011011442A (es) 2011-11-18
ES2625949T3 (es) 2017-07-21
ZA201107708B (en) 2012-07-25
KR20120015332A (ko) 2012-02-21
AU2010243907A1 (en) 2011-11-03
SG175184A1 (en) 2011-12-29
MY174008A (en) 2020-03-03
US20180235909A1 (en) 2018-08-23
PT2424514T (pt) 2017-05-30
EP2424514A1 (en) 2012-03-07
US20160346228A1 (en) 2016-12-01
CN105640927A (zh) 2016-06-08
EP2424514B1 (en) 2017-02-22
US20100280128A1 (en) 2010-11-04
JP2012525344A (ja) 2012-10-22
KR20190095522A (ko) 2019-08-14
KR20210027513A (ko) 2021-03-10
PH12017500270A1 (en) 2017-09-04
US20170326079A1 (en) 2017-11-16
SI2424514T1 (sl) 2017-05-31
IL215695A (en) 2015-11-30
CA2757757C (en) 2017-10-24
JP5993303B2 (ja) 2016-09-14
KR20170005189A (ko) 2017-01-11
SG10201401455WA (en) 2014-07-30
CN102438607A (zh) 2012-05-02
PL2424514T3 (pl) 2017-08-31
DK2424514T3 (en) 2017-05-08
CA2757757A1 (en) 2010-11-04
HUE032695T2 (en) 2017-10-30
CY1118822T1 (el) 2018-01-10
LT2424514T (lt) 2017-04-25
AU2010243907C1 (en) 2015-09-03
EP3069717A1 (en) 2016-09-21
WO2010124856A1 (en) 2010-11-04
AU2010243907B2 (en) 2015-04-23
IL215695A0 (en) 2012-01-31
HRP20170551T1 (hr) 2017-06-02

Similar Documents

Publication Publication Date Title
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
BR112012013260A2 (pt) dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BR112013011874A2 (pt) compostos e métodos para tratar dor
BR112012031836A2 (pt) combinação farmacêutica para o tratamento da dor
UY33094A (es) Procedimiento para la preparacion de dronedarona
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
BR112014013843A2 (pt) uso de dispositivos para o tratamento de doenças neurológicas
BR112012004836A2 (pt) pirazinilpiridinas úteis para o tratamento de doenças proliferativas
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BRPI1014528A2 (pt) compostos para tratamento de inflamação e dor
BRPI1007995A2 (pt) orto-aminoamidas para o tratamento de cãncer.
BRPI0918050A2 (pt) compostos de tetraciclina para o tratamento de artrite reumatoide e metodos relacionados de tratamento
BRPI1009448A2 (pt) combinações farmacêuticas compreendendo edea119/bay 869766 para o tratamento de cânceres específicos
BRPI0922367A2 (pt) enzastaurin para o tratamento de câncer
BRPI0912890A2 (pt) composição farmacêutica para o tratamento de ejaculação precoce
BRPI0915927A2 (pt) uso de inibiodores de hdac para o tratamento da doença de hodgkin
BRPI0814409A2 (pt) Tratamento de dor neuropática
BRPI1014720A2 (pt) uso de compostos de 1-fenil-3-dimetilaminopropano para o tratamento da dor reumatoide

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]